Announcements Trials
Browse Landscape

Phase

Phase 2 36Phase 3 13Phase 1 4Phase NA 3Phase 4 3Phase 1/2 2Phase EARLY_PHASE1 1Phase 2/3 1

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 3OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2Sexuality 1Osteoporosis 1Fractures, Bone 1Bone Diseases, Metabolic 1

Interventions

Dexamethasone 49Metformin 47Cyclophosphamide 42Saline Solution 38Cytarabine 34Sodium Chloride 32Bupivacaine 31Vincristine 27Cisplatin 26Propofol 25Methotrexate 25Letrozole 24Fluorouracil 24Dexmedetomidine 24Doxorubicin 23Fentanyl 22Carboplatin 22Etoposide 19Rituximab 18Morphine 18Bevacizumab 18Acetaminophen 18Lidocaine 17Granulocyte Colony-Stimulating Factor 17Prednisone 16Mercaptopurine 16Docetaxel 16Clomiphene 16Sevoflurane 15Ropivacaine 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × OTHER × Aromatase Inhibitors × Clear all
NCT05362760 2025-05-16

MINERVA

University of Ulm

Phase 4 Recruiting
300 enrolled
Breast

Breast Neoplasms

NCT02467686 2017-03-20

Cimicifuga

Irmandade da Santa Casa de Misericordia de Sao Paulo

Phase 4 Unknown
60 enrolled

Sexuality

NCT00766532 2012-09-14

Do Aromatase Inhibitors (AIs) Decrease Intestinal Calcium Absorption?

University of Wisconsin, Madison

Phase 4 Completed
12 enrolled 5 charts
Breast

Bone Diseases, Metabolic, Breast Neoplasms, Osteoporosis, Fractures, Bone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡